Animal and Veterinary Innovation Centers (U18)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
If your institution has veterinary or animal health research capacity, FDA will fund multi-year partnerships on HPAI, genomic animal innovations, or unmet veterinary medical needs.
Report stale or inaccurate summary
What this is
This is a cooperative agreement opportunity for academic institutions to conduct research addressing three FDA veterinary priorities: preventing or controlling Highly Pathogenic Avian Influenza in animals, advancing regulatory science for intentional genomic alterations that support agriculture and food security, and developing veterinary products for minor species or unmet medical needs in major species. Awards up to $1.25M support long-term partnerships with the FDA's Center for Veterinary Medicine. This is suited for established research institutions with veterinary or animal health expertise and capacity to manage multi-year cooperative agreements.
Who can apply
Eligible applicants are public institutions of higher education, private institutions of higher education, and other organizations as specified in additional eligibility text (typically includes research hospitals and certain non-profits). Solo founders and small businesses are not eligible; this requires institutional research infrastructure and capacity.
Eligible applicant types
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Full description — from the agency
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM). This includes CVM developing cooperative agreement(s) with academic research institutions (public and private) to: 1. Drive research that supports the development of interventions to prevent, control, or eliminate Highly Pathogenic Avian Influenza (HPAI) virus in animals, or interventions that reduce the circulation of the virus in the ecosystem. Work may also include other emerging zoonotic disease threats or One Health issues in future years. 2. Drive research that supports the development of intentional genomic alternations in animals and the advancement of regulatory science in this field, with a focus on intentional genomic alternations that support agricultural resilience, food security, animal health, or public health. 3. Drive research that supports the development of products for minor species, minor uses in major species (dogs, cats, horses, cattle, pigs, chickens, and turkeys) and other unmet veterinary medical needs in major species that create a significant animal or public health burden.
Topics: animal health research · avian influenza prevention · genomic alterations animals · veterinary innovation · FDA partnerships · minor species drugs · veterinary medical needs
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.